Cas no 1229627-25-1 (2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid)

2-Chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid is a fluorinated pyridine derivative with significant utility in pharmaceutical and agrochemical research. Its trifluoromethylphenyl and carboxylic acid functional groups enhance its reactivity, making it a versatile intermediate for synthesizing bioactive compounds. The chloro substituent at the 2-position further increases its potential for selective derivatization. This compound exhibits high purity and stability under standard conditions, ensuring reliable performance in cross-coupling reactions and other transformations. Its structural features contribute to improved lipophilicity and metabolic stability in drug development applications. The product is particularly valuable in the design of enzyme inhibitors and receptor modulators due to its electron-withdrawing properties and rigid aromatic framework.
2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid structure
1229627-25-1 structure
Product Name:2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid
CAS No:1229627-25-1
MF:C13H7ClF3NO2
MW:301.648392915726
CID:2618330
PubChem ID:53223959
Update Time:2025-06-08

2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid Chemical and Physical Properties

Names and Identifiers

    • 2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid
    • 2-Chloro-5-(3-(trifluoromethyl)phenyl)nicotinicacid
    • 2-Chloro-5-(3-(trifluoromethyl)phenyl)nicotinic acid
    • 2-Chloro-5-(3-trifluoromethylphenyl)nicotinic acid, 95%
    • DTXSID60687977
    • 1229627-25-1
    • 2-CHLORO-5-(3-TRIFLUOROMETHYLPHENYL)NICOTINIC ACID
    • MFCD16621994
    • Inchi: 1S/C13H7ClF3NO2/c14-11-10(12(19)20)5-8(6-18-11)7-2-1-3-9(4-7)13(15,16)17/h1-6H,(H,19,20)
    • InChI Key: SIBUWJSYTABOQC-UHFFFAOYSA-N
    • SMILES: ClC1=C(C(=O)O)C=C(C=N1)C1C=CC=C(C(F)(F)F)C=1

Computed Properties

  • Exact Mass: 301.012
  • Monoisotopic Mass: 301.012
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 6
  • Heavy Atom Count: 20
  • Rotatable Bond Count: 2
  • Complexity: 364
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 50.2A^2
  • XLogP3: 3.9

2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A013008003-250mg
2-Chloro-5-(3-(trifluoromethyl)phenyl)nicotinic acid
1229627-25-1 97%
250mg
$489.60 2023-09-03
Alichem
A013008003-500mg
2-Chloro-5-(3-(trifluoromethyl)phenyl)nicotinic acid
1229627-25-1 97%
500mg
$782.40 2023-09-03
Alichem
A013008003-1g
2-Chloro-5-(3-(trifluoromethyl)phenyl)nicotinic acid
1229627-25-1 97%
1g
$1519.80 2023-09-03

2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid Related Literature

Additional information on 2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid

Comprehensive Analysis of 2-Chloro-5-[3-(Trifluoromethyl)Phenyl]Pyridine-3-Carboxylic Acid (CAS 1229627-25-1)

2-Chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid (CAS 1229627-25-1) is a high-value heterocyclic compound widely used in pharmaceutical and agrochemical research. Its unique structure, featuring a pyridine core substituted with a chloro group and a trifluoromethylphenyl moiety, makes it a versatile intermediate for synthesizing bioactive molecules. Recent studies highlight its potential in drug discovery, particularly for targeting inflammatory pathways and enzyme inhibition, aligning with the growing demand for precision medicine solutions.

The compound’s carboxylic acid functional group enables facile derivatization, a key reason for its popularity in medicinal chemistry. Researchers are exploring its applications in small-molecule therapeutics, especially for kinase inhibitors—a hot topic in oncology research. With the rise of AI-driven drug design, computational models frequently reference CAS 1229627-25-1 as a scaffold for optimizing ADME properties (absorption, distribution, metabolism, excretion). This aligns with industry trends favoring fragment-based drug discovery.

In agrochemicals, 2-chloro-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid serves as a precursor for crop protection agents. Its trifluoromethyl group enhances lipophilicity, improving membrane permeability—a critical factor for pesticide efficacy. As sustainability gains traction, this compound’s role in developing low-residue formulations resonates with green chemistry initiatives. Patent databases reveal its use in herbicide-resistant trait development, addressing global food security challenges.

Synthetic routes to CAS 1229627-25-1 often involve Pd-catalyzed cross-coupling or nucleophilic aromatic substitution, topics frequently searched in organic synthesis forums. Process optimization remains a focus, with flow chemistry emerging as a scalable alternative to batch methods. Analytical characterization via HPLC-MS and NMR spectroscopy confirms its high purity (>98%), a prerequisite for regulatory submissions in GMP-compliant production.

Market-wise, the compound’s demand correlates with orphan drug development and biosimilar formulations. Suppliers emphasize custom synthesis services, catering to niche R&D needs. Environmental concerns drive interest in biodegradable intermediates, positioning 1229627-25-1 as a candidate for eco-friendly redesign. Its stability under accelerated storage conditions (40°C/75% RH) further supports commercial viability.

Future prospects include exploring metal-organic frameworks (MOFs) for controlled release applications and catalytic asymmetric synthesis to access enantiopure derivatives. As blockchain technology permeates supply chains, traceability of high-purity intermediates like this compound gains importance for IP protection and anti-counterfeiting measures.

Recommended suppliers
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hunan Well Medicine Synthesis Technology Co., Ltd.
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Wuhan Comings Biotechnology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Wuhan Comings Biotechnology Co., Ltd.
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd